Patents by Inventor Nir Peled

Nir Peled has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMERSION COOLING FOR INTEGRATED CIRCUIT DEVICES
    Publication number: 20220201889
    Abstract: A two-phase immersion cooling system for an integrated circuit assembly may be formed utilizing boiling enhancement structures formed on or directly attached to heat dissipation devices within the integrated circuit assembly, formed on or directly attached to integrated circuit devices within the integrated circuit assembly, and/or conformally formed over support devices and at least a portion of an electronic board within the integrated circuit assembly. In still a further embodiment, the two-phase immersion cooling system may include a low boiling point liquid including at least two liquids that are substantially immiscible with one another.
    Type: Application
    Filed: December 21, 2020
    Publication date: June 23, 2022
    Applicant: Intel Corporation
    Inventors: Raanan Sover, James Williams, Bradley Smith, Nir Peled, Paul George, Jason Armstrong, Alexey Chinkov, Meir Cohen, Je-Young Chang, Kuang Liu, Ravindranath Mahajan, Kelly Lofgreen, Kyle Arrington, Michael Crocker, Sergio Antonio Chan Arguedas
  • Apparatus for treating a target site of a body
    Patent number: 11351397
    Abstract: Apparatus for performing a procedure at a target site of a patient's body, the apparatus comprising: a continuous positive airway pressure (CPAP) apparatus that provides CPAP to the patient's lungs; a medical device for performing the procedure at the target site; and a controller that controls the CPAP apparatus to provide CPAP to the patient's lungs during performance of the procedure.
    Type: Grant
    Filed: October 22, 2014
    Date of Patent: June 7, 2022
    Assignee: Tel Hashomer Medical Research, Infrastructure and Services Ltd.
    Inventors: Jeffrey Goldstein, Nir Peled, Zvi Symon
  • Breath analysis of pulmonary nodules
    Patent number: 9528979
    Abstract: The present invention provides a unique profile of volatile organic compounds as breath biomarkers for lung cancer. The present invention further provides the diagnosis, prognosis and monitoring of lung cancer or predicting the response to an anti-cancer treatment through the detection of the unique profile of volatile organic compounds indicative of lung cancer at its various stages.
    Type: Grant
    Filed: November 15, 2012
    Date of Patent: December 27, 2016
    Assignees: TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD., TEL HASHOMER MEDICAL RESEARCH, INFRASTRUCTURE AND SERVICES LTD.
    Inventors: Hossam Haick, Nir Peled
  • APPARATUS FOR TREATING A TARGET SITE OF A BODY
    Publication number: 20160256710
    Abstract: Apparatus for performing a procedure at a target site of a patient's body, the apparatus comprising: a continuous positive airway pressure (CPAP) apparatus that provides CPAP to the patient's lungs; a medical device for performing the procedure at the target site; and a controller that controls the CPAP apparatus to provide CPAP to the patient's lungs during performance of the procedure.
    Type: Application
    Filed: October 22, 2014
    Publication date: September 8, 2016
    Inventors: Jeffrey GOLDSTEIN, Nir PELED, Zvi SYMON
  • Volatile organic compounds for detecting cell dysplasia and genetic alterations associated with lung cancer
    Patent number: 9315848
    Abstract: The present invention provides methods of identifying a genetic abnormality such as mutation in EGFR or KRAS or ALK which is associated with the management of lung cancer or diagnosing, prognosing or monitoring the treatment of pre-cancerous conditions of the lung, such as bronchial dysplasia or atypical alveolar hyperplasia (AAH), through the detection of at least one volatile organic compound indicative of these states.
    Type: Grant
    Filed: August 17, 2011
    Date of Patent: April 19, 2016
    Assignees: TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD., THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Hossam Haick, Nir Peled
  • VOLATILE ORGANIC COMPOUNDS FOR DETECTING CELL DYSPLASIA AND GENETIC ALTERATIONS ASSOCIATED WITH LUNG CANCER
    Publication number: 20130143247
    Abstract: The present invention provides methods of identifying a genetic abnormality such as mutation in EGFR or KRAS or ALK which is associated with the management of lung cancer or diagnosing, prognosing or monitoring the treatment of pre-cancerous conditions of the lung, such as bronchial dysplasia or atypical alveolar hyperplasia (AAH), through the detection of at least one volatile organic compound indicative of these states.
    Type: Application
    Filed: August 17, 2011
    Publication date: June 6, 2013
    Applicant: TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.
    Inventors: Hossam Haick, Nir Peled
  • COMPOSITIONS AND METHODS OF COUNTERACTING RESIDUAL SEDATIVE EFFECTS OF SLEEP/ HYPNOTIC DRUGS
    Publication number: 20120295893
    Abstract: The present invention provides pharmaceutical compositions comprising a flumazenil, and methods of alleviating or counteracting residual effects (e.g. drowsiness) associated with the administration of sleep/hypnotic drugs or alleviating effects of alcohol intoxication, using self administration modes of delivery.
    Type: Application
    Filed: December 14, 2010
    Publication date: November 22, 2012
    Applicant: COERULEUS LTD.
    Inventors: Nir Peled, David Solomon, Amir Toren